About: Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?
Creator	Bullock, & Crawford-Manning, F Jinks, & Paskins, Z
Source	Medline; PMC
abstract	SUMMARY: The COVID-19 pandemic is influencing methods of healthcare delivery. In this short review, we discuss the evidence for remote healthcare delivery in the context of osteoporosis. INTRODUCTION: The COVID-19 pandemic has undoubtedly had, and will continue to have, a significant impact on the lives of people living with, and at risk of, osteoporosis and those caring for them. With osteoporosis outpatient and Fracture Liaison Services on pause, healthcare organisations have already moved to delivering new and follow-up consultations remotely, where staffing permits, by telephone or video. METHODS: In this review, we consider different models of remote care delivery, the evidence for their use, and the possible implications of COVID-19 on osteoporosis services. RESULTS: Telemedicine is a global term used to describe any use of telecommunication systems to deliver healthcare from a distance and encompasses a range of different scenarios from remote clinical data transfer to remote clinician-patient interactions. Across a range of conditions and contexts, there remains unclear evidence on the acceptability of telemedicine and the effect on healthcare costs. Within the context of osteoporosis management, there is some limited evidence to suggest telemedicine approaches are acceptable to patients but unclear evidence on whether telemedicine approaches support informed drug adherence. Gaps in the evidence pertain to the acceptability and benefits of using telemedicine in populations with hearing, cognitive, or visual impairments and in those with limited health literacy. CONCLUSION: There is an urgent need for further health service evaluation and research to address the impact of remote healthcare delivery during COVID-19 outbreak on patient care, and in the longer term, to identify acceptability and cost- and clinical-effectiveness of remote care delivery on outcomes of relevance to people living with osteoporosis.
has issue date	2020-06-16(xsd:dateTime)
bibo:doi	10.1007/s00198-020-05465-2
bibo:pmid	32548787
has license	no-cc
sha1sum (hex)	7a1e6efc72eb4a978c41afca1fcbe6bbc9b7e575
schema:url	https://doi.org/10.1007/s00198-020-05465-2
resource representing a document's title	Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?
has PubMed Central identifier	PMC7297512
has PubMed identifier	32548787
schema:publication	Osteoporos Int
resource representing a document's body	covid:7a1e6efc72eb4a978c41afca1fcbe6bbc9b7e575#body_text
is schema:about of	named entity 'deliver' named entity 'Results' named entity 'describe' named entity 'Gaps' named entity 'evidence' named entity 'With' named entity 'osteoporosis' named entity 'COVID-19' named entity 'COVID-19' named entity 'RESULTS' named entity 'INTRODUCTION' named entity 'OUTCOMES' named entity 'CLINICIAN' named entity 'OSTEOPOROSIS MANAGEMENT' named entity 'CONTEXT' named entity 'RELEVANCE' named entity 'USE' named entity 'ACROSS' named entity 'MODELS' named entity 'HEALTHCARE' named entity 'TO DELIVER' named entity 'USED' named entity 'RISK OF' named entity 'FRACTURE' named entity 'CONTINUE' named entity 'COVID-19' named entity 'LIAISON' named entity 'EFFECT' named entity 'INTERACTIONS' named entity 'CARING' named entity 'CONSULTATIONS' named entity 'NEED FOR' named entity 'RESEARCH' named entity 'TO IDENTIFY' named entity 'TELECOMMUNICATION' named entity 'TERM' named entity 'SERVICES' named entity 'remote' named entity 'remote' named entity 'influencing' named entity 'permits' named entity 'evidence' named entity 'conditions' named entity 'identify' named entity 'telemedicine' named entity 'data transfer' named entity 'healthcare delivery' named entity 'acceptable' named entity 'care' named entity 'evidence' named entity 'address' named entity 'patient' named entity 'implications' named entity 'COVID-19' named entity 'telemedicine' named entity 'data transfer' named entity 'health service' named entity 'healthcare delivery' named entity 'patient care' named entity 'COVID-19 pandemic' named entity 'health literacy' named entity 'pertain' named entity 'telecommunication' named entity 'healthcare delivery' named entity 'osteoporosis' named entity 'COVID-19 pandemic' named entity 'outpatient' named entity 'care delivery' named entity 'telemedicine' named entity 'telemedicine' named entity 'moved' named entity 'evaluation' named entity 'informed' named entity 'COST' named entity 'OUTBREAK' named entity 'OSTEOPOROSIS' named entity 'CARE DELIVERY' named entity 'AT RISK'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software